Does Medicaid cover Mounjaro?
Medicaid usually covers Mounjaro (tirzepatide) for type 2 diabetes when it's on your state's formulary, but coverage for weight loss is a different matter — many states exclude weight-loss drugs entirely.
What flips the answer
- Covered when
It's prescribed for type 2 diabetes, is on your state's formulary/preferred drug list, and prior authorization (and any step therapy) is satisfied.
- Not covered when
It's being used for weight loss in a state that excludes weight-loss drugs from Medicaid coverage.
- Not covered when
It's not on your state's preferred drug list, or required prior-authorization / step-therapy criteria aren't met.
Mounjaro is the tirzepatide brand approved for type 2 diabetes. For that use, it's covered by many state Medicaid programs when it appears on the state's formulary or preferred drug list — typically subject to prior authorization and sometimes step therapy (trying other diabetes drugs first).
Weight loss is separate. Tirzepatide is sold under a different brand (Zepbound) for obesity, and federal law lets Medicaid programs exclude drugs used for weight loss. So a request for Mounjaro-class medication to lose weight may not be covered in a state that opts out of weight-loss drug coverage, even if the same drug is covered for diabetes.
Because it comes down to your state's drug list and prior-authorization rules for the specific diagnosis, the reliable move is to check your state's preferred drug list and have the prescriber document the qualifying diagnosis and any required prior authorization.
Formulary placement, prior-authorization, and step-therapy rules are set by each state; whether weight-loss use is covered depends on the state's weight-loss-drug election.
That's the general answer. Yours is written in your actual policy.
Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.
Check my policy →